Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
Chansaenroj J, Yorsaeng R, Puenpa J, Wanlapakorn N, Chirathaworn C, Sudhinaraset N, Sripramote M, Chalongviriyalert P, Jirajariyavej S, Kiatpanabhikul P, Saiyarin J, Soudon C, Thienfaidee O, Ayuthaya TPN, Brukesawan C, Intharasongkroh D, Chaiwanichsiri D, Issarasongkhram M, Kitphati R, Mungaomklang A, Thitithanyanont A, Nagavajara P, Poovorawan Y.
Chansaenroj J, et al. Among authors: thitithanyanont a.
PLoS One. 2022 Apr 21;17(4):e0267102. doi: 10.1371/journal.pone.0267102. eCollection 2022.
PLoS One. 2022.
PMID: 35446889
Free PMC article.